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SUMMARY
This study examines the validity of using ICD-10 codes to identify hospitalized pneumonia cases.
Using a case-cohort design, subjects were randomly selected from monthly cohorts of patients aged
o65 years discharged from April 2000 to March 2002 from two large tertiary Australian hospitals.
Cases had ICD-10-AM codes J10–J18 (pneumonia) ; the cohort sample was randomly selected
from all discharges, frequency matched to cases by month. Codes were validated against three
comparators: medical record notation of pneumonia, chest radiograph (CXR) report and both.
Notation of pneumonia was determined for 5098/5101 eligible patients, and CXR reports reviewed
for 3349/3464 (97%) patients with a CXR. Coding performed best against notation of pneumonia:
kappa 0.95, sensitivity 97.8% (95% CI 97.1–98.3), speciﬁcity 96.9% (95% CI 96.2–97.5), positive
predictive value (PPV) 96.2% (95% CI 95.4–97.0) and negative predictive value (NPV) 98.2%
(95% CI 97.6–98.6). When medical record notation of pneumonia is used as the standard, ICD-10
codes are a valid method for retrospective ascertainment of hospitalized pneumonia cases and
appear superior to use of complexes of symptoms and signs, or radiology reports.
INTRODUCTION
All-cause pneumonia is an important clinical
endpoint for determining vaccine eﬀectiveness (VE)
for 23-valent pneumococcal polysaccharide vaccine
(23vPPV) and inﬂuenza vaccine. It represents a
greater part of the burden of disease due to these
organisms, and a trade-oﬀ between a highly speciﬁc
but insensitive outcome measure such as pneumonia
associated with pneumococcal bacteraemia or
microbiologically proven inﬂuenza and a sensitive,
but non-speciﬁc surrogate outcome such as all-
cause mortality. However, accurate identiﬁcation
of pneumonia cases is not straightforward. Clinical
criteria alone are imprecise [1]. There remains no
internationally agreed deﬁnition for pneumonia based
on clinical symptoms and signs and no one sign or
symptom, nor combination of these has ever been
shown to clearly diﬀerentiate pneumonia from other
respiratory illnesses [2–4]. There is also no ideal di-
agnostic test for microbiological diagnosis [1], and
while chest radiograph (CXR) is often useful to con-
ﬁrm the diagnosis of pneumonia and its severity [1], it
also has limitations [5, 6]. Because of the diﬃculties
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in deﬁning and identifying cases of pneumonia using
clinical, radiological or microbiological criteria, codes
from the International Classiﬁcation of Diseases
(ICD), overseen by the World Health Organization
(WHO), are frequently used as surrogate measures to
identify hospitalized patients with pneumonia in stu-
dies of VE for 23vPPV and inﬂuenza vaccine [7–11].
These codes have become the international standard
for disease classiﬁcation [12].
Use of standardized codes to retrospectively identify
cases of pneumonia among hospitalized patients is
appealing to researchers primarily because of time
eﬃciencies (comparedwith the alternative of reviewing
hospital records for clinical, radiological and/or lab-
oratory evidence consistent with pneumonia). Despite
the practical advantages and continued use of ICD
codes by researchers to identify cases of pneumonia,
at the time of this research only two small studies
(<150 subjects) have examined the validity of this
approach for all-cause pneumonia [13, 14], while a
third has examined codes for pneumococcal pneu-
monia [15]. These studies, all from North America,
used ICD-9-CM codes and suggested ICD codes may
be a valid tool for case ascertainment of pneumonia.
However, further examination is prudent given the
paucity of available data and the potential for diﬀer-
ences in other settings. As part of a case-cohort study
[16, 17] examining VE for 23vPPV and inﬂuenza
vaccine against pneumonia in the elderly in Australia
where these vaccines are provided free of charge, we
examined the validity of ICD-10-AM codes to identify
cases of pneumonia among hospitalized patients.
METHODS
Study subjects
Cases of pneumonia were identiﬁed from monthly
separation lists of completed admissions for patients
aged o65 years from two major teaching hospitals
(Royal Melbourne Hospital and Western Hospital
Footscray) for the period 1 April 2000 to 31 March
2002, using ICD-10-AM codes J10–J18 (pneumonia
including those cases due to inﬂuenza) [18]. These two
hospitals represent about 11%of the total hospitalized
population and 13% of all hospitalizations for pneu-
monia for those agedo65 years in Victoria [19]. Eight
coders at each hospital (each with a three-year uni-
versity degree in Health Information Management)
assigned codes as per Australian standards [20].
Pneumonia was identiﬁed if one ormore of these codes
appeared in any of the 14 diagnostic code positions
for each hospital separation. Cases were also eligible
for selection in the cohort as a case-cohort design. If
a subject appeared on the hospital separation list
more than once in any given month, one episode was
selected at random, and the rest excluded from
analysis. For month-to-month repeat separations
for pneumonia for an individual, the ﬁrst selected
admission was retained and subsequent episodes
excluded to minimize any Hawthorne eﬀect from
study participation aﬀecting vaccination status [21].
Patients were excluded from monthly separation lists
if not resident in Victoria or if admitted for short-stay
procedures such as dialysis and chemotherapy (ICD-
10-AM codes Z49.1, Z49.2 and Z51.1). Cohort sub-
jects were randomly selected from monthly separation
lists, frequency-matched to the cases. Over-sampling
was conducted to allow for subsequent exclusion of
repeat admissions in the cohort, as well as those sub-
jects also selected as cases. After exclusions, a total of
1.2 times the number of cases was selected using a
random number generator. A cohort subject could be
selected only once each month and admissions selec-
ted for the same subject in subsequent months were
excluded.
Examination of the validity of codes for subgroups
of microbiologically proven pneumococcal pneu-
monia (J13) or pneumonia associated with proven
inﬂuenza (J10 and J11) was not conducted due to
small numbers in these subgroups (S. pneumoniae
pneumonia was coded in only 11 ﬁrst-presentation
pneumonia cases, and there were none coded as in-
ﬂuenza pneumonia).
Development of comparators for pneumonia ICD-10
codes
Given the diﬃculty of deﬁning a reference standard
for the diagnosis of pneumonia, three comparators
were developed for the purpose of examining the
validity of ICD-10 coded cases using retrospective
chart review: (1) medical record notation of ‘pneu-
monia’, (2) CXR report and (3) both, since in-
terpretation of both clinical and radiological ﬁndings
is generally used in clinical practice to make a deﬁni-
tive diagnosis of pneumonia. As ICD-10 codes were
not integrated with the database until after com-
pletion of the study, record review occurred blinded
to coding status.
Hospital records for the selected admission were
reviewed for notation of ‘pneumonia’ as a diagnosis
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considered probable by the clinical team under whose
care the patient was admitted. This notation was con-
sidered most likely to be consistent with a diagnosis of
pneumonia given it would be based on all information
available to the clinical team at the time of discharge
(thus having both face and content validity). To
examine relevance of signs and symptoms in retro-
spective identiﬁcation of pneumonia, for patients with
notation of pneumonia, the documentation of cough,
sputum production, pleuritic chest pain, fever
o37.5 xC, shortness of breath, crackles (crepitations),
and aspiration was also sought (deﬁnitely present,
deﬁnitely absent or not recorded); these being the
most common symptoms and signs of pneumonia
suggested by descriptive studies of pneumonia [3, 22].
Two trained research assistants used pre-speciﬁed
criteria to interpret radiologists’ reports for all study
subjects with CXRs undertaken as part of routine
management. Pneumonia was deﬁned as ‘ lobar ’ (any
opacity conﬁned to a lobar anatomical distribution),
‘bronchopneumonia’ (opacity distributed beyond a
single lobe in conjunction with terms that are similar
to or include the words ‘patchy’ and/or ‘airspace’),
‘other’ (opacity consistent with pneumonia not pre-
viously classiﬁed) and ‘not pneumonia’ (none of the
above).
For patients with more than one CXR during their
selected admission, the ﬁrst abnormal report was re-
viewed blinded to other reports. When reports could
not be conﬁdently interpreted, two of the in-
vestigators (S.S., a paediatrician, and D.C., an adult
respiratory physician) made the ﬁnal assessment.
High inter-operator agreement was ﬁrst established
on a sample of pilot subjects (the study was piloted in
full for 1 month prior to study commencement). We
independently reviewed CXR reports for consecutive
groups of 20 pilot subjects and compared interpret-
ation for agreement. No further groups were ex-
amined and review of study reports did not commence
until a kappa statistic [23] indicating >95% concur-
rence was achieved. Consensus was obtained on sub-
sequent ‘ in dispute’ reports after independent review
and before data entry. For the main analysis, out-
comes were categorized as ‘consistent with pneu-
monia’ (lobar pneumonia, bronchopneumonia or
other pneumonia) or not.
Statistical methods
The validity of ICD-10 codes for identiﬁcation of
cases of pneumonia in hospitalized patients was
examined by comparing codes J10–J18 as a group vs.
the three comparators. Sensitivity, speciﬁcity, positive
predictive value (PPV) and negative predictive value
(NPV) were calculated using STATA version 9.1 [24]. In
addition, because of the absence of a true reference
standard, raw data are presented with percentage
agreement between ICD-10 codes and the compara-
tors and kappa statistics (agreement adjusted for
chance agreement) were calculated. The eﬀect of
hospital of separation and season on coding validity
was examined using stratiﬁcation. The inﬂuenza sea-
son, deﬁned by inﬂuenza surveillance independent of
this study [25] was used as a proxy for a period of
increased pneumonia activity.
To determine the extent of any eﬀect of repeat ad-
mission for pneumonia on coding practices, analyses
were repeated with inclusion of all selected subjects.
The study was approved by the Human Research
Ethics Committee, Melbourne Health (ref. 2000.022).
Free and informed consent was obtained from sub-
jects or their legal guardians.
RESULTS
Study subjects
There were 2319 ﬁrst presentations coded as pneu-
monia and 2912 ﬁrst-presentation cohort subjects,
including 130 who were also selected as cases, giving a
total of 5101 eligible study subjects (Figures 1 and 2).
The mean age of eligible subjects was 77 years and
2740 (54%) were male. CXRs were conducted for
3464/5101 (68%) subjects (96% of cases and 47% of
cohort subjects), and of these 3349 (97%) (97% of
cases and 97% of cohort subjects) had radiology re-
ports available for review.
Validity using medical record notation of pneumonia
as the comparator
Clinical notation of pneumonia (yes/no) was able
to be determined for 5098/5101 subjects (99.9%). Of
these, 2281 (45%) had pneumonia documented as a
probable diagnosis, representing 2230/2318 (96%)
ICD-10-coded cases and 51/2780 (2%) ICD-10-coded
non-cases. Among cohort subjects, 128/179 (72%)
pneumonia notations had pneumonia deﬁned by
ICD-10 codes. There was a very high level of agree-
ment between ICD-10-coded pneumonia or non-
pneumonia and clinical notation, with a kappa
statistic of 0.95 and high sensitivity, speciﬁcity, PPV
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and NPV (Table 1). Stratiﬁcation by season and hos-
pital of selection indicated these factors did not play
an important role, with small diﬀerences between
strata in real terms (range 0.1–5.5%).
Among the 2281 subjects with notation of pneu-
monia, a median of four (range 0–6) of the seven
symptoms and signs of interest were present. Three or
more were present in 1911/2281 (84%). The symp-
toms and signs that were most frequently recorded as
present or absent and that were present most often
were crackles (92%), shortness of breath (74%),
cough (71%), fever o37.5 xC (66%) and sputum
production (54%) (Table 2).
Validity using CXR as the comparator
Of 5101 eligible subjects, 3464 (68%) had had a CXR
conducted, representing 2239/2329 (96%) subjects
with ICD codes for pneumonia and 1374/2927 (47%)
subjects not coded as having pneumonia. Eighty-
seven of 5101 (1.7%) subjects had no CXR performed
and an ICD-coded diagnosis of pneumonia. In total,
3345/3464 (97%) subjects with a CXR had radiology
reports available for review and 1724/3345 (51%)
with CXR reports had some form of pneumonia
based on review (bronchopneumonia 24.8%, lobar
pneumonia 24.8%, other pneumonia 0.2%, not
pneumonia 46.8%, investigator unsure 0.1%). This
represented 1538/2154 (71%) ICD-10-coded cases
and 186/1191 (16%) ICD-10-coded non-cases with a
report. A good level of agreement was present be-
tween pneumonia status according to ICD-10 codes
and CXR report (kappa 0.52) (Table 1). No diﬀerence
in estimates was found when stratifying by season,
and only one diﬀerence in strata-speciﬁc estimates for
NPV when stratifying by hospital suggesting a true
diﬀerence (x5.5, 95% CIx9.8 tox1.3).
Validity using CXR plus medical record notation of
pneumonia as the comparator
The level of agreement was similar to that of CXR
report alone (kappa 0.60) (Table 1). Indicators of
validity were within the range provided by the pre-
vious two comparators, except for PPV which was
lower (Table 1). Stratiﬁcation indicated no eﬀect of
season or hospital of separation on estimates (data
not shown). Estimates for validity also changed very
little when all cases of pneumonia were included
rather than just ﬁrst presentations (data not shown).
ICD-10 codes and diagnostic positions used for
pneumonia
The most common ICD-10 codes used and the diag-
nostic positions (1–14) in which they occurred during
the study period for the 2319 eligible ﬁrst-presentation
cases of pneumonia are shown in Table 3. Eight sub-
jects (0.3%) had two codes for pneumonia assigned.
By far the most common ICD-10 code used for cases
of pneumonia was J18.9 (pneumonia, unspeciﬁed)
which comprised 91.5% (2122/2319) of all ﬁrst cases of
pneumonia. The next most common codes were J18.0
Selected cohort 3204 
Records reviewed 3127 (98%)
7 lost records 70 ineligible 
1st presentations 2927 (91%) 
15 repeat cases 
2912 eligible 
200 repeat admissions 
Fig. 2. Flow chart of eligible ﬁrst-presentation cohort
subjects.
Selected cases 2670
Records reviewed 2612 (98%)
51 ineligible
1st presentation cases 2329 (89%)
2319 eligible 
5 lost records, 2 duplicates
283 repeat admissions
10 repeat cohort co-members
Fig. 1. Flow chart of eligible ﬁrst-presentation cases, based
on ICD-10 codes J10–J18.
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(bronchopneumonia, unspeciﬁed) : 1.6% (37/2319)
and J15.1 (pneumonia due to Pseudomonas) : 1.4%
(32/2319). Of ﬁrst-presentation cases of pneumonia
with codes J10–J18 listed, codes for pneumonia
occurred most frequently in diagnostic position 1
(50.8%). A total of 82% of cases were documented
in the ﬁrst four positions and 95% in the ﬁrst eight
positions.
DISCUSSION
These data conﬁrm the validity of ICD-10 codes for
the retrospective identiﬁcation of persons discharged
from hospital with a diagnosis of pneumonia. Using
medical record notation of pneumonia as the com-
parator, we were able to exclude estimates for sensi-
tivity, speciﬁcity, PPV and NPV of less than 95%.
Given that coding staﬀ are trained to translate
hospital record notations into codes in a way that
captures as much information as possible [20], rather
than by searching for individual symptoms and signs,
these data conﬁrm that the coding process is being
performed at a high standard in the two hospitals
studied.
This study found somewhat higher levels of internal
validity for ICD-10 coding as a tool for identifying
persons discharged from hospital with pneumonia
than previous studies conducted outside Australia
using ICD-9 codes [13–15]. The diﬀerences in re-
sults may be explained by diﬀerences in design (see
below) or setting (e.g., coding practices or training).
In Victoria, for instance, a high level of training is
required for clinical coders, there is linking of hospital
funding to codes, and annual audits of coding accu-
racy are conducted by independent and/or govern-
ment agencies. In general, results from earlier studies
were nonetheless favourable towards use of ICD
codes as a diagnostic tool.
Marrie and colleagues examined ICD-9-CM codes
(011.6, 021.2, 136.3, 480–487, 506–507) in a prospec-
tive study of 105 adult patients hospitalized with
pneumonia [13, 26]. Codes 480–487 correspond to
ICD-10-AM codes J10–J18 [18]. The comparator
utilized was clinical pneumonia diagnosed within 48 h
of admission by medical staﬀ, plus a new opacity on
CXR consistent with pneumonia conﬁrmed by the
researchers. The study estimated sensitivity of 69%
and PPV of 57% for these ICD codes as a group.
Another small study of agreement compared 144
ICD-9-CM classiﬁed cases of community-acquired
pneumonia (CAP) (codes 480–487 plus 13 other codes
that might capture pneumonia [27]) with a reference
standard for pneumonia using retrospective review of
clinical records and CXR reports [14]. Conﬁrmation
of CAP by clinical review required symptoms com-
patible with pneumonia within 24 h of admission and
a report consistent with pneumonia from a CXR
within 48 h of admission. Where the diagnostic code
for CAP was in the principal diagnosis position,
compared with review of clinical records, codes had
a sensitivity of 84%, speciﬁcity of 86%, PPV of 92%
and kappa of 0.68. A further study by Guevara
and colleagues is not directly comparable as the in-
vestigators examined the validity of ICD-9-CM codes
for the subcategory of pneumococcal pneumonia
against various clinical deﬁnitions [15]. Inclusion cri-
teria for the analysis of CAP requiring hospitalization
included age o18 years, CXR within 48 h of ad-
mission consistent with pneumonia in a patient with
any one of fever, abnormal white blood cell count,
hypothermia or productive cough. With removal of
the narrowest of the six diagnostic coding groups
(code for pneumococcal septicaemia only: 38.20),
ranges for a combination of codes indicative of
pneumococcal pneumonia were sensitivity (55–85%)
and NPV (93–95%) [15]. With removal of the
Table 1. Validity of ICD-10 coding vs. three comparators
Comparator
Cases
(J10–J18)
Non-cases
(other codes) Kappa
Sensitivity
(95% CI)
Speciﬁcity
(95% CI)
PPV
(95% CI)
NPV
(95% CI)
CXR report
(n=3345)
1538/2154 1005/1191 0.52 89.2 62.0 71.4 84.4
71% 84% (87.7–90.6) (59.6–64.4) (69.4–73.3) (82.2–86.4)
Notation of
pneumonia
(n=5098)
2230/2318 2729/2780 0.95 97.8 96.9 96.2 98.2
96% 98% (97.1–98.3) (96.2–97.5) (95.4–97.0) (97.6–98.6)
Both
(n=3343)
1509/2153 34/1190 0.60 97.8 64.2 68.1 97.1
70% 2.9% (96.9–98.5) (62.0–66.4) (68.1–72.0) (96.1–98.1)
CI, Conﬁdence interval ; PPV, positive predictive value ; NPV, negative predictive value.
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broadest of the six diagnostic coding groups (all six
evaluated codes : 38.20, 481.00, 38.00, 482.30, 518.81,
486.00), the range for speciﬁcity and PPV was
96–100% and 72–95% respectively. A recent study
conducted since completion of our study conﬁrms
estimates for validity in the same range as the studies
by Marrie et al. and Guevara et al. [28]. Aronsky and
colleagues compared ICD-9 codes 480–483 plus
485–487 with a reference standard requiring: a CXR
report compatible with pneumonia, an ICD-9 code
for or discharge diagnosis of pneumonia, at least a 1%
probability of pneumonia calculated by a decision
support system [29], notation of ‘pneumonia’ in the
medical notes and a consensus vote of pneumonia as
the diagnosis by three independent physicians.
Estimates for validity were: sensitivity 55% (95% CI
48–61), speciﬁcity 99% (95% CI 99–99), PPV 84%
(95% CI 77–90) and NPV 96% (95% CI 95–97).
Our choice of ICD-10-AM codes J10–J18 to identi-
fy cases of hospitalization of pneumonia is consistent
with previous studies examining VE of inﬂuenza
vaccine and 23vPPV against pneumonia [7, 8, 10, 11,
30]. Most researchers have utilized ICD-9 codes
480–487, equivalent to ICD-10-AM codes J10–J18 [7,
10, 11, 30]. Two of the previous studies examining
validity of ICD-9 codes used a more inclusive set of
codes [13, 14] which may also partially explain their
lower levels of estimated validity.
Although this study did not examine individual
signs and symptoms consistent with pneumonia for all
participants, previous studies suggest that symptom
complexes are likely to be inferior to ICD-10 codes as
a tool for researchers to retrospectively identify cases
of pneumonia [2–4]. In our study, review of hospital
records for subjects with notation of pneumonia
found 84% had at least three of the seven symptoms
and signs of interest.
It may not be surprising that using radiology re-
ports as a reference standard to deﬁne pneumonia
retrospectively did not result in close agreement with
ICD-10 codes. First, non-speciﬁc language was often
used. Words such as ‘opacity’ were frequently used
to describe the appearance of a CXR rather than
reporting a deﬁnitive diagnosis, and may indicate
pathology other than pneumonia. We did not attempt
to review chest radiographs themselves. While it is
possible that radiologist review of CXRs (rather than
of their associated reports) may be of greater diag-
nostic value, limited data suggest this is also imper-
fect. One study of 282 patients with pneumonia
conﬁrmed by a radiologist found that the agreement
rate by a further two radiologists was only 79% [5].
A standardized approach to the interpretation of
adult CXRs is not yet available, however, future de-
velopments may improve the usefulness of radiology
reports in reference standards for pneumonia for fu-
ture studies. Although a standardized approach to
interpretation of paediatric CXRs has been devel-
oped, this has not yet been correlated with clinical
disease and is only valid for prospective studies fol-
lowing speciﬁc training of reviewers [31].
Code J18.9 for ‘unspeciﬁed pneumonia’ comprised
over 91% of all hospital separations for pneumonia.
Therefore while ICD-10 codes are both sensitive and
speciﬁc for the identiﬁcation of all-cause pneumonia,
they are unlikely to be helpful, at least in this setting,
for the identiﬁcation of subcategories of pneumonia.
A key limitation in this area of research is the lack
of a reference standard for diagnosis of pneumonia
against which to compare ICD-10 codes. However,
analyses were conducted using three comparators
suggested by review of the literature and this study
was large enough to exclude a sensitivity, speciﬁcity,
NPV and PPV for ICD-10 codes for pneumonia of
Table 2. Frequency of symptoms and signs extracted from medical records
for subjects with notation of pneumonia as a probable diagnosis (n=2281)
Symptom or sign
Present
n (%)
Absent
n (%)
Not recorded
n (%)
Crackles 2110 (92.5) 138 (6.0) 33 (1.5)
Shortness of breath 1680 (73.6) 496 (21.7) 105 (4.6)
Cough 1623 (71.1) 437 (19.2) 221 (9.7)
Fevero37.5 xC 1508 (66.1) 764 (33.5) 9 (0.4)
Sputum production 1229 (53.9) 757 (33.2) 295 (12.9)
Pleuritic chest pain 508 (22.3) 915 (40.1) 858 (37.6)
Evidence of aspiration 154 (6.7) 469 (20.6) 1658 (72.7)
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Table 3. ICD-10 codes used to describe pneumonia by diagnostic code position (1–14)
Code Description Rank 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Total %
J10.0 Inﬂuenza with pneumonia, inﬂuenza virus identiﬁed 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0
J11.0 Inﬂuenza with pneumonia, virus not identiﬁed 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0
J11.1 Inﬂuenza with other respiratory
manifestations, virus not identiﬁed
13 0 0 0 0 2 0 0 0 0 0 0 0 0 0 2 0.0
J12.9 Viral pneumonia, unspeciﬁed 14 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0.0
J13 Pneumonia due to Streptococcus pneumoniae 7 8 2 0 0 0 0 1 0 0 0 0 0 0 0 11 0.5
J14 Pneumonia due to Haemophilus inﬂuenzae 5 10 4 1 0 2 0 0 0 0 0 0 0 0 0 17 0.7
J15.0 Pneumonia due to Klebsiella pneumoniae 10 0 1 2 1 0 0 0 1 2 1 0 0 0 0 8 0.3
J15.1 Pneumonia due to Pseudomonas 3 9 12 2 2 2 2 1 0 0 2 0 0 0 0 32 1.4
J15.2 Pneumonia due to staphylococcus 4 8 6 7 1 0 1 1 0 1 0 3 1 0 0 29 1.3
J15.3 Pneumonia due to streptococcus, group B 8 10 0 0 0 0 0 0 0 0 0 0 0 0 0 10 0.4
J15.4 Pneumonia due to other streptococci 10 3 2 1 0 1 0 0 0 0 0 0 1 0 0 8 0.3
J15.5 Pneumonia due to Escherichia coli 13 0 0 0 2 0 0 0 0 0 0 0 0 0 0 2 0.1
J15.6 Pneumonia due to other aerobic
Gram-negative bacteria
9 5 1 0 0 0 1 0 0 0 1 0 1 0 0 9 0.4
J15.7 Pneumonia due to Mycoplasma pneumoniae 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0
J15.8 Other bacterial pneumonia 12 1 0 0 0 0 1 0 0 0 0 0 1 0 0 3 0.1
J15.9 Bacterial pneumonia, unspeciﬁed 14 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0.0
J16.8 Pneumonia due to other speciﬁed
infectious organisms
12 0 0 0 0 1 1 0 0 1 0 0 0 0 0 3 0.1
J17.0 Pneumonia in bacterial diseases classiﬁed elsewhere 9 0 5 1 0 2 0 0 0 0 0 1 0 0 0 9 0.4
J17.2 Pneumonia in mycoses 11 0 1 0 2 0 1 0 0 0 0 0 0 0 0 4 0.2
J17.3 Pneumonia in parasitic diseases 14 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0.0
J17.8 Pneumonia in diseases classiﬁed elsewhere 13 0 2 0 0 0 0 0 0 0 0 0 0 0 0 2 0.1
J18.0 Bronchopneumonia, unspeciﬁed 2 20 5 3 1 2 0 2 0 0 1 0 1 1 1 37 1.6
J18.1 Lobar pneumonia, unspeciﬁed 6 8 2 1 0 0 0 0 1 0 0 0 0 0 0 12 0.5
J18.8 Other pneumonia, organisms unspeciﬁed 11 2 1 0 0 0 0 0 1 0 0 0 0 0 0 4 0.2
J18.9 Pneumonia, unspeciﬁed 1 1096 387 165 105 83 74 60 43 29 18 27 15 11 9 2122 91.5
Total — 1182 432 183 114 95 81 65 46 33 23 31 20 12 10 2327 —
% 50.8 18.6 7.9 4.9 4.1 3.5 2.8 2.0 1.4 1.0 1.3 0.9 0.5 0.4
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less than 95% when compared with medical record
notationof pneumonia.Kappa statistics for agreement
were very high. There were few missing data for any
comparator, with 97% of radiology reports available
for eligible subjects, and notation of pneumonia able
to be determined for all but three subjects. Selection
bias was minimized by random selection of the co-
hort, frequency sampling by month, and exclusion of
non-Victorian residents. Measurement bias was re-
duced by blinding data collectors to ICD-coded case
status, rigorous training and monitoring, and piloting
of the study. Estimates made using all episodes of
pneumonia were virtually identical to those made
using only ﬁrst presentations, suggesting that repeat
presentations were not coded diﬀerently and their
exclusion from the primary analyses was unlikely to
have biased the estimates of validity. Generalizability
to the wider population of hospitalized elderly per-
sons in Victoria may be limited, however, the two
participating hospitals were very large central tertiary
centres and likely to be representative of this setting.
In conclusion, when medical record notation of
pneumonia is used as the standard, we found ICD-10
codes are a valid method for retrospective ascertain-
ment of hospitalized cases of pneumonia and are
likely to be superior to use of complexes of symptoms
and signs, or interpretation of radiology reports.
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